Colgate

At close, the Sensex was up 539.83 points or 0.66 percent at 82,726.64, and the Nifty was up 159.00 points or 0.63 percent at 25,219.90. About 1,883 shares advanced, 1,987 shares declined, and 162 shares unchanged.

Stock of the Day: Colgate-Palmolive India: Strong Volume Growth Amid Tough Market Conditions

Colgate continued to lead in the oral-care category, and there is a large headroom for growth, given the lower penetration and high rural salience (40 percent of sales). Although increasing penetration in rural areas remains a key growth driver, it could be an uphill task in the medium term, while the growing personal-care segment presents a significant opportunity. Category development, new communication programmes and expanding rural reach will accelerate growth.

Neutral Colgate; target of Rs 3250: Motilal Oswal

Motilal Oswal recommended Neutral rating on Colgate with a target price of Rs 3250 in its research report dated November 27, 2024.

Brokerages split on Colgate Palmolive's plans to drive volumes, topline growth

Colgate Palmolive (India) is also focusing on areas beyond oral care, with plans to bring more products from its global parent company's portfolio to India.

Neutral Colgate; target of Rs 3150: Motilal Oswal

Motilal Oswal recommended Neutral rating on Colgate with a target price of Rs 3150 in its research report dated July 29, 2024.

Brokerages give thumbs up to Colgate on strong Q1 volume growth; stock hits record high

Colgate's growth in rural markets has outpaced urban markets for the second consecutive quarter. Its toothpaste portfolio saw double-digit growth driven by high single-digit volume growth, higher than industry rival Hindustan Unilever's mid-single digit growth which was driven by pricing.

Colgate India Q1: Net Profit rises 33% to Rs 364 crore, sales up at 33%

Total revenue of the company is Rs 1,485.8 crore rising 13 percent from the year ago period. Domestic revenues grew by 12.8 percent year-on-year for the quarter.

Colgate-Palmolive gets mixed reviews on Q4 show, shares down 6% in two sessions

We expect volume growth for Colgate to remain range-bound in FY25 despite an expected rural recovery, said internatonal brokerage Nomura.

Colgate aims to push for growth while sustaining margins, says CFO

The company does not foresee any spike in input costs for the immediate quarters.

Gainers and Losers: 10 stocks that moved the most on May 15

At close, the Sensex was down 117.58 points or 0.16 percent at 72,987.03, and the Nifty was down 17.30 points or 0.08 percent at 22,200.55 on May 15

Colgate-Palmolive Q4 results: Net profit rises 20% to Rs 380 crore

Colgate-Palmolive Q4: Total revenue came at Rs 1,480.66 crore, rising 10.35 percent in the year-ago quarter, the personal-care company said in a regulatory filing on May 13.

FMCG sector faces obstacles as raw material costs rise: BNP Paribas

Higher prices of raw materials such as crude oil, palm oil, and lactic acid bacteria (used in dairy products) quarter-on-quarter and year-on-year present a challenge to consensus margin estimates, BNP Paribas said.

Neutral Colgate; target of Rs 2400: Motilal Oswal

Motilal Oswal recommended Neutral rating on Colgate with a target price of Rs 2400 in its research report dated January 22, 2024.

Colgate-Palmolive India posts Q3 profit jump on lower expenses, urban demand

Net profit rose to 3.30 billion rupees ($39.7 million) for the quarter ended Dec. 31 from 2.43 billion rupees a year earlier.

Amazon customer orders Sony headphones, gets Colgate instead. Watch

The customer, identified as Yash Ojha, took to X (formerly Twitter) where he shared a video of unboxing the Amazon delivery and finding out that a Colgate tube had been sent to him instead of Sony headphones.

Neutral Colgate; target of Rs 2020 : Motilal Oswal

Motilal Oswal recommended Neutral rating on Colgate with a target price of Rs 2020 in its research report dated October 26, 2023.

Short Call | Street looks for 'next best ideas' as focus shifts to MCX, Colgate, Dr Lal Path Labs

The street is unfazed by Friday’s net sales figure as well. The view is that mutual funds are sitting on enough cash, having sold shares when FIIs were on a buying spree since May